O11-5 Durvalumab(D) ± tremelimumab(T) + platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN
Title:
O11-5 Durvalumab(D) ± tremelimumab(T) + platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN
Author:
Saito, Haruhiro Goldman, Jonathan W. Garassino, Marina Chiara Chen, Yuanbin Reinmuth, Niels Hotta, Katsuyuki Poltoratskiy, Artem Trukhin, Dmytro Hochmair, Maximilian J. Özgüroğlu, Mustafa Ji, Jun Ho Statsenko, Galina Voitko, Oleksandr Conev, Nikolay V. Bondarenko, Igor Spencer, Stuart Xie, Mingchao Jones, Stephanie Franks, April Shrestha, Yashaswi Paz-Ares, Luis